drugset / Trial / NCT06615570
A Phase 1 Dose Escalation Study of VX-973 in Healthy Participants
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of VX-973 in healthy participants.
Timeline
- Start
- 2024-09-30
- Primary completion
- 2025-07-21
- Completion
- 2025-07-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VX-973 | Unknown | — | Oral |
Indications
No indication recorded.